Lataa...

Effect of liraglutide vs. placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: a randomized controlled trial

AIMS: To examine how circulating GLP-1 concentrations during liraglutide treatment relate to its therapeutic actions on glucose and weight, and to study the effects of liraglutide on other proglucagon-derived peptides (PGDPs), including endogenous GLP-1, GLP-2, glucagon, oxyntomodulin, glicentin, an...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Obes Metab
Päätekijät: Kim, Sun H., Abbasi, Fahim, Nachmanoff, Clara, Stefanakis, Konstantinos, Kumar, Ajay, Kalra, Bhanu, Savjani, Gopal, Mantzoros, Christos S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7856054/
https://ncbi.nlm.nih.gov/pubmed/33140542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14242
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!